Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis

NCT02242071 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

BIOLOGICAL: Stem Cell

Sponsor

Neurogen Brain and Spine Institute